Literature DB >> 19414117

Identification, characterization, and biological relevance of prostate cancer stem cells from clinical specimens.

Susan Kasper1.   

Abstract

Cancer stem cells (CSCs) are a reservoir of tumor cells that exhibit the properties of self-renewal and the ability to re-establish the heterogeneous cell population of a tumor. They appear therapy-resistant and may be the underlying cause of recurrent disease. Using prostate as a model, this review presents the CSC hypothesis and discusses the role of the androgen receptor in CSCs, the methods used for isolating CSCs, and the therapeutic challenges CSCs have for cancer therapy.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19414117      PMCID： PMC2799332          DOI： 10.1016/j.urolonc.2008.12.012

Source DB:  PubMed          Journal:  Urol Oncol        ISSN： 1078-1439            Impact factor:   3.498


  37 in total

1.  Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species.

Authors:  M A Goodell; M Rosenzweig; H Kim; D F Marks; M DeMaria; G Paradis; S A Grupp; C A Sieff; R C Mulligan; R P Johnson
Journal:  Nat Med       Date:  1997-12       Impact factor: 53.440

2.  Identification of a cellular receptor for transforming growth factor-beta in rat ventral prostate and its negative regulation by androgens.

Authors:  N Kyprianou; J T Isaacs
Journal:  Endocrinology       Date:  1988-10       Impact factor: 4.736

Review 3.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

4.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.

Authors:  D Bonnet; J E Dick
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

Review 5.  Exploring the origins of the normal prostate and prostate cancer stem cell.

Authors:  Susan Kasper
Journal:  Stem Cell Rev       Date:  2008-09       Impact factor: 5.739

6.  Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium.

Authors:  E J Robinson; D E Neal; A T Collins
Journal:  Prostate       Date:  1998-11-01       Impact factor: 4.104

7.  Identification of novel Prominin-1/CD133 splice variants with alternative C-termini and their expression in epididymis and testis.

Authors:  Christine A Fargeas; Angret Joester; Ewa Missol-Kolka; Andrea Hellwig; Wieland B Huttner; Denis Corbeil
Journal:  J Cell Sci       Date:  2004-08-15       Impact factor: 5.285

Review 8.  Stem cell origin of cancer and differentiation therapy.

Authors:  Stewart Sell
Journal:  Crit Rev Oncol Hematol       Date:  2004-07       Impact factor: 6.312

Review 9.  Stem cells, aging, and cancer: inevitabilities and outcomes.

Authors:  Deborah R Bell; Gary Van Zant
Journal:  Oncogene       Date:  2004-09-20       Impact factor: 9.867

10.  CD133, a novel marker for human prostatic epithelial stem cells.

Authors:  Gavin D Richardson; Craig N Robson; Shona H Lang; David E Neal; Norman J Maitland; Anne T Collins
Journal:  J Cell Sci       Date:  2004-06-29       Impact factor: 5.285
View more
  18 in total

Review 1.  Role of Sonic Hedgehog (Shh) Signaling in Bladder Cancer Stemness and Tumorigenesis.

Authors:  Islam S Syed; Akbari Pedram; Walid A Farhat
Journal:  Curr Urol Rep       Date:  2016-02       Impact factor: 3.092

Review 2.  Actions of estrogens and endocrine disrupting chemicals on human prostate stem/progenitor cells and prostate cancer risk.

Authors:  Wen-Yang Hu; Guang-Bin Shi; Dan-Ping Hu; Jason L Nelles; Gail S Prins
Journal:  Mol Cell Endocrinol       Date:  2011-09-05       Impact factor: 4.102

3.  Novel strategies targeting cancer stem cells through phytochemicals and their analogs.

Authors:  Prasad Dandawate; Subhash Padhye; Aamir Ahmad; Fazlul H Sarkar
Journal:  Drug Deliv Transl Res       Date:  2013-04-01       Impact factor: 4.617

4.  Expression of nodal and nodal receptors in prostate stem cells and prostate cancer cells: autocrine effects on cell proliferation and migration.

Authors:  BaoHan T Vo; Shafiq A Khan
Journal:  Prostate       Date:  2011-01-12       Impact factor: 4.104

Review 5.  Overview of cancer stem cells (CSCs) and mechanisms of their regulation: implications for cancer therapy.

Authors:  Bin Bao; Aamir Ahmad; Asfar S Azmi; Shadan Ali; Fazlul H Sarkar
Journal:  Curr Protoc Pharmacol       Date:  2013-06

Review 6.  The cancer stem cell niche--there goes the neighborhood?

Authors:  Stephanie M Cabarcas; Lesley A Mathews; William L Farrar
Journal:  Int J Cancer       Date:  2011-09-14       Impact factor: 7.396

7.  Integrin αv expression is required for the acquisition of a metastatic stem/progenitor cell phenotype in human prostate cancer.

Authors:  Christel van den Hoogen; Geertje van der Horst; Henry Cheung; Jeroen T Buijs; Rob C M Pelger; Gabri van der Pluijm
Journal:  Am J Pathol       Date:  2011-09-09       Impact factor: 4.307

8.  A novel in vitro model for cancer stem cell culture using ectopically expressed piwil2 stable cell line.

Authors:  Maryam Shahali; Maryam Kabir-Salmani; Karim Nayernia; Hamid Reza Soleimanpour-Lichaei; Mohammad Vasei; Seyed Javad Mowla; Ehsan Ranaie; Mehdi Shakibaie; Mohammad Hossein Modaresi
Journal:  Cell J       Date:  2013-08-24       Impact factor: 2.479

9.  Effects of Sorafenib, a Tyrosin Kinase Inhibitor, on Adrenocortical Cancer.

Authors:  Lidia Cerquetti; Barbara Bucci; Salvatore Raffa; Donatella Amendola; Roberta Maggio; Pina Lardo; Elisa Petrangeli; Maria Rosaria Torrisi; Vincenzo Toscano; Giuseppe Pugliese; Antonio Stigliano
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-24       Impact factor: 5.555

10.  Drug treatment of cancer cell lines: a way to select for cancer stem cells?

Authors:  Ilaria Chiodi; Cristina Belgiovine; Francesca Donà; A Ivana Scovassi; Chiara Mondello
Journal:  Cancers (Basel)       Date:  2011-03-04       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.